Table 1.

The attributes of neurologists who completed the survey and distribution of their responses (n = 453).

Attributes and responses	n (%)	95% CI of proportions (%)
Specialization
•General Neurologist	362 (79.8)	75.9-83.3
•Epileptologist	55 (12.1)	9.0-15.0
•Pediatric Neurologist	29 (6.4)	4.4-9.0
•Epilepsy surgeon	8 (1.8)	0.8-3.5
Work setup
•Teaching hospital	158 (34.8)	30.6-39.3
•Corporate hospital	160 (35.2)	31.0-39.8
•Own individual practice	136 (30)	25.9-34.4
Years of experience
•< 5 years	153 (33.7)	29.5-38.2
•5-15 years	145 (31.9)	27.8-36.4
•>15 years	156 (34.4)	30.2-38.9
Number of epilepsy patients seen in a week before pandemic
•<5	34 (7.5)	5.3 -10.3
•5-10	108 (23.8)	20.1-27.9
•11-20	150 (33)	28.9 -37.6
•>20	162 (35.7)	31.4-40.3
COVID-19 patients being admitted in their hospital	322 (70.9)	66.7-75.1
Department member tested positive for COVID-19	235 (51.8)	47.3-56.4
Comfortable in offering antiseizure medicine withdrawal	212 (46.7)	42.3-51.4
Patients willing for antiseizure medicine withdrawal
•Yes	200 (44.1)	39.7-48.8
•No	178 (39.2)	34.9-43.9
•Not discussed	76 (16.7)	13.6-20.5
COVID testing mandatory before video-EEG monitoring (n=222)	163 (72)	31.7-40.5
Approximate number of patients who had breakthrough seizures due to difficulty in accessing medical care
•Less than 10	240 (52.9)	48.4-57.5
•10-20	152 (33.5)	29.4-38.1
•>20	62 (13.6)	10.8-17.1
Any patient had life threatening seizures due to difficulty in accessing medical care	129 (28.4)	24.5-32.8
Use of teleconsultation since the onset of COVID pandemic
•Routinely	205 (45.2)	40.7-49.9
•Seldom	172 (37.9)	33.6-42.5
•Not at all	77 (17)	13.8-20.7
Patients demanding teleconsultation during pandemic	363 (80)	76.2-83.6
Impact of COVID pandemic on your practice of epileptology
•Significant	304 (67)	62.7-71.3
•Insignificant	136 (30)	25.9-34.4
•Not at all	14 (3)	1.8-5.1

CI – confidence interval.